Multicenter Study Assessing the Efficacy and Safety of DE-126 Ophthalmic Solution 0.002% Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension

Rochester Ophthalmological Group, P.C., Rochester

Wills Eye Hospital, Philadelphia

Duke Eye Center, Durham

Coastal Research Associates, Roswell

Clayton Eye Clinical Research, LLC, Morrow

Levenson Eye Associates, Jacksonville

Mayo Clinic, Dept. of Opthamology, Jacksonville

Bowden Eye & Associates, Jacksonville

Shettle Eye Research, Largo

Apex Eye Clinical Research, LLC, Cincinnati

Vance Thompson Vision - ND, West Fargo

The Cataract and Glaucoma Center, El Paso

University of Colorado, Dept. of Opthamology, Aurora

Arizona Glaucoma Specialists, Phoenix

Arizona Eye Center, Chandler

Nevada Eye Care Professionals, Las Vegas

Premiere Practice Management, Los Angeles

University of California, Los Angeles, Doheny Eye Centers, Pasadena

North Valley Eye Medical Group, Mission Hills

North Bay Eye Associates, Inc, Petaluma

Walman Eye Center, Sun City

Global Research Management, Glendale

The Eye Research Foundation, Newport Beach

Sacramento Eye Consultants, Sacramento

Hernando Eye Institute, Brooksville

Eye Associates of Fort Myers, Fort Myers

Dixophthal PC dba Dixon Eye Care, Albany

Clinical Eye Research of Boston, LLC, Winchester

AdvanceMed Clinical Research-Las Vegas, Las Vegas

Northern New Jersey Eye Institute, South Orange

Wake Forest Health Network Ophthamology - Oak Hollow, High Point

Office of Mark J. Weiss MD, Tulsa

Scott & Christie and Associates PC, Cranberry Township

Black Hills Regional Eye Institute, Rapid City

University Eye Specialists, Maryville

VRF Eye Specialty Group, Memphis

Glaucoma Associates of Texas, Dallas

DCT- Shah Research LLC dba Discovery Clinical Trials, Mission

San Antonio Eye Center, San Antonio

R and R Eye Research LLC, San Antonio

Stacy R. Smith M.D. P.C., Salt Lake City